Differential regulation of the release of tumor necrosis factor-α and of eicosanoids by mast cells in rat airways after antigen challenge

Mediators of Inflammation

Volumn 12, Issue 4, 2003, Pages 237-246

  Trezena, Aryene Goes ^a   Da Silva, Zilma Lucia ^b   Oliveira Filho, Ricardo Martins ^b   Damazo, Amilcar Sabino ^c   Straus, Anita Hilda ^d   Takahashi, Helio Kiyoshi ^d   Oliani, Sonia Maria ^c   De Lima, Wothan Tavares ^b  

^a INSTITUTO BUTANTAN   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Airways; Asthma; Eicosanoids; Mast cells; Rat; TNF

Indexed keywords

COMPOUND 48-80; DEXAMETHASONE; ICOSANOID; OVALBUMIN; TUMOR NECROSIS FACTOR ALPHA;

AIRWAY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SECRETION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EVALUATION; INCUBATION TIME; MALE; MAST CELL; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROVOCATION TEST; RAT; REGULATORY MECHANISM; SENSITIZATION; TRACHEA;

ANIMALS; BRONCHIAL PROVOCATION TESTS; DEXAMETHASONE; EICOSANOIDS; GLUCOCORTICOIDS; MALE; MAST CELLS; OVALBUMIN; P-METHOXY-N-METHYLPHENETHYLAMINE; RATS; RATS, WISTAR; TRACHEA; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 0142093533     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09629350310001599684     Document Type: Article

References (62)

1. Schefler AL. The National Asthma Education Program Attacks Asthma. J Allergy Clin Immunol 1991; 87: 468-469.
2. Prussin C, Metcalfe DD. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 2003; 111: S486-S494.
3. Lazarus SC. Inflammation, inflammatory mediators, and mediator antagonists in asthma J Clin Pharmacol 1998; 38: 577-582.
4. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiology 1997; 77: 1033-1079.
5. Kips JC, Tavernier JH, Joos GF, Peleman RA, Pauwels RA, The potential role of tumour necrosis factor alpha in asthma. Clin Exp Allergy 1993; 23: 247-250.
6. Broide DH, Lotz M, Cuomo AJ, Cuburn DA, Federman EC, Wasserman SI. Cytokines in symptomatic asthma airways. J Allergy Clin Immunol 1992; 89: 958-967.
7. Ying S, Robinson DS, Varney V, et al. TNF-alpha mRNA expression in allergic inflammation. Clin Exp Allergy 1991; 21: 745-750.
8. Watson ML, Smith D, Bourne AD. Thompson RC, Westwick J. Cytokines contribute to airway dysfunction in antigen-challenged guinea pigs: inhibition of airway hyperreactivity, pulmonary eosinophil accumulation, and tumor necrosis factor generation by pretreatment with an interleukin-1 receptor antagonist. Am J Respir Cell Mol Biol 1993; 8. 365-369.
9. Renzetti LM, Paciorek PM, Tannu SA, et al. Pharmacological evidence for tumor necrosis factor as a mediator of allergic inflammation in the airways. J Pharmacol Exp Ther 1996; 278: 847-853.
10. Lazaar AL, Amrani Y, Hsu J, et al. CD40-mediated signal transduction in human airway smooth muscle. J Immunol 1998; 161: 3120-3127.
11. Amrani Y, Aubier M, Bronner C. Interaction between tumor necrosis factor-alpha and the smooth muscle cells of the airway: implication in the physiopathology of asthma. Rer Mal Respir 1996; 13: 539-546.
12. Amrani Y. Chen H, Panettieri RA. Activation of tumor necrosis factor receptor 1 in airway smooth muscle: a potential pathway that modulates bronchial hyper-responsiveness in asthma? Respir Res 2000; 1: 49-53.
13. Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF. Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci USA 1991; 15: 4220-4224.
14. Bradding P, Roberts JA, Britten KM, et al. Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994; 10: 471-480.
15. Bradding P, Mediwake R, Feather IH, et al. TNF alpha is localized to nasal mucosal mast cells and is released in acute allergic rhinitis Clin Exp Allergy 1995; 25: 406-415.
16. Williams MM, Galli SJ. The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. J Allergy Clin Immunol 2000; 105: 847-859.
17. Walmrath D, Schneider U, Kreusler B, Grimminger F, Ennis M, Seeger W. Intravascular anti-IgE challenge in perfused lungs: mediator release and vascular pressor response. J Appl Physiol 1991; 71: 2499-2506.
18. Matsuoka T, Hirata M, Tanaka H, et al. Prostaglandin D2 as a mediator of allergic asthma. Science 2000; 287: 2013-2017.
19. Fedan JS, Frazer DG. Influence of epithelium on the reactivity of guinea pig isolated, perfused trachea to bronchoactive drugs. J Pharmacol Exp Ther 1992; 262: 741-750.
20. McGrogan I, Janssen LJ, Wattie J, O'Byrne PM, Daniel EE. Release of epithelium-derived PGE2 from canine trachea after antigen inhalation. Am J Physiol 1998; 274: L220-L225.
21. Vargaftig BB, Lefort J. Differential effects of prostacyclin and prostaglandin E1 on bronchoconstriction and thrombocytopenia during collagen and arachidonate infusions and anaphylactic shock in the guinea-pig. Prostaglandins 1979; 18: 519-528.
22. Savla U, Appel HJ, Sporn PH, Waters CM. Prostaglandin E(2) regulates wound closure in airway epithelium. Am J Physiol Lung Cell Mol Physiol 2001; 280: L421-L431.
23. Lipworth BJ. Fortnightly review: modern drug treatment of chronic asthma. Br Med J 1999; 318: 380-384.
24. Henderson WRJr. Role of leukotrienes in asthma. Ann Allergy 1994; 72: 272-278.
25. Panettieri Jr RA, Murray RK, Eszterhas AJ, Bilgen G, Martin JG. Repeated allergen inhalations induce DNA synthesis in airway smooth muscle and epithelial cells in vivo. Am J Physiol 1998; 274: L417-L424.
26. Phan SH, McGarry BM, Loeffler KM, Kunkel SL. Regulation of macrophage-derived fibroblast growth factor release by arachidonate metabolites. J Leukocyte Biol 1987; 42: 106-113.
27. Wang CG, Du T, Xu J, Martin JG. The role of leukotriene D4 in allergen-induced increases in airway smooth muscle in the rat. Am Rev Respir Dis 1993; 148: 413-417.
28. Enerbäck L. Mucosal mast cells in the rat and in man. Int Arch Allergy Appl Immunol 1987; 82: 249-255.
29. Okuda M. Functional heterogeneity of airway mast cells. Allergy 1999; 57: 50-62.
30. McNeil HP, Gotis-Graham I. Human mast cell subsets - distinct functions in inflammation? Inflamm Res 2000; 49; 3-7.
31. Riley JR, West GB. Tissue mast cell. Studies with a histamine-liberator of low toxicity (compound 48/80). J Pathol Bact 1955; 69: 269-282.
32. Marone G, Spadaro G, De Marino V, Aliperta M, Triggiani M. Immunopharmacology of human mast cells and basophils. Int J Clin Lab Res 1998; 28: 12-22.
33. Bernstein JA, Lawrence ID. The mast cell: a comprehensive, updated review. Allergy Proc 1990; 11: 209-223.
34. Tam EK, Calonico LD, Nadel JA, McDonald M. Globule leukocyte and mast cells in the rat trachea: their number, distribution, and response to compound 48/80 and dexamethasone. Anat Embryol 1988; 178: 107-118.
35. Tavares de Lima W, Silva ZL. Contractile responses of proximal and distal trachea segments isolated from rats subjected to immunological stimulation: role of connective tissue mast cells. Gen Pharmacol 1998; 30: 689-695.
36. Flick DA, Gifford GA. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J Immunol Methods 1984; 68: 167-175.
37. Pradelles P, Grassi J, Maclouf J. Enzyme immunoassays of eicosanoids using acetylcholine esterase as a label: an alternative to radioimmunoassay. Anal Chem 1985; 57: 1170-1173.
38. Strauss AH, Travassos LR, Takahashi HK. A monoclonal antibody (ST-1) directed to the native heparin chain. Anal Biochem 1992; 201: 1-8.
39. Gibbs L, Carollo MG, Damazo AS, Oliani SM, Perretti M. Time-dependent expression of annexin 1 in a model of chronic granulomatous inflammation. Inflamm Res 2002; 51: 300-306.
40. Lulich KM, Papadimitriou JM, Paterson JW. The isolated lung strip and single open tracheal ring: a convenient combination for characterizing Schultz Dale anaphylactic contractions in the peripheral and central airways of the guinea-pig. Clin Exp Pharmacol Physiol 1979; 6: 625-629.
41. Frossard N, Rhoden KJ, Barnes PJ. Influence of epithelium on guinea pig airway responses to tachykinins: role of endopeptidase and cyclooxygenase. J Pharmacol Exp Ther 1989; 248: 292-298.
42. Proust B, Nahori MA, Ruffie C, Lefort J, Vargaftig BB. Persistence of bronchopulmonary hyper-reactivity and eosinophilic lung inflammation after anti-IL-5 or -IL-13 treatment in allergic BALB/c and IL-4Ralpha knockout mice. Clin Exp Allergy 2003; 33: 119-131.
43. Laan M, Prause O, Miyamoto M, et al. A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF-alpha. Eur Respir J 2003; 21: 387-393.
44. Pennings HJ, Kramer K, Bast A, Buurman WA, Wouters EF. Tumour necrosis factor-alpha induces hyperreactivity in tracheal smooth muscle of the guinea-pig in vitro. Eur Respir J 1998; 12: 45-49.
45. Anticevich SZ, Hughes JM, Black JL, Armour CL. Induction of human airway hyperresponsiveness by tumour necrosis factor-alpha Eur J Pharmacol 1995; 284: 221-225.
46. Olejnik AK, Brzezinska-Blaszczyk E. Tumor necrosis factor alpha (TNF-O modulates rat mast cell reactivity. Immunol Lett 1998; 64: 167-171.
47. Schmidt-Choudhury A, Furuta GT, Lavigne JA, Galli SJ, Wershil BK. The regulation of tumor necrosis factor-alpha production in murine mast cells: pentoxifylline or dexamethasone inhibits IgE-dependent production of TNF-alpha by distinct mechanisms. Cell Immunol 1996; 171: 140-146.
48. Galli SJ. The Paul Kallos Memorial Lecture. The mast cell: a versatile effector cell for a challenging world. Int Arch Allergy Immunol 1997; 113: 14-22.
49. Souharada M, Klein JJ, Berend N, Souharada JF. Topographical diferences in the physiological response of canine airway smooth muscle. Resp Physiol 1983; 52: 245-258.
50. Zimmerman I, Walkkenhorst M, Ulmer WT. The location of sensoric bronchoconstricting receptors in the upper airways. Respiration 1999; 38: 1-11.
51. Elias MO, Tavares de Lima W, Vannuchi YB, Marcourakis T, da Silva ZL, Trezena AG, Scavone C. Nitric oxide modulates Na+ , K+, ATPase activity through cyclic GMP pathway in proximal rat trachea. Eur J Pharmacol 1999; 367: 307-314.
52. Damazo AS, Tavares de Lima W, Perretti M, Oliani SM. Pharmacological modulation of allergic inflammation in the airways and association with mast cell heterogeneity. Eur J Pharmacol 2001; 426: 123-130.
53. Oliani SM, Christian HC, Manston J, Flower RJ, Perretti M. An immunocytochemical and in situ hybridization analysis of annexin 1 expression in rat mast cells: modulation by inflammation and dexamethasone. Lab Invest 2000; 80: 1429-1438.
54. Snyder DS, Beller DI, Unanue ER. Prostaglandins modulate macrophage Ia expression. Nature 1982; 299: 163-165.
55. Olejnik AK, Brzezinska-Blaszczyk E. Tumor necrosis factor alpha (TNF-alpha) modulates rat mast cell reactivity. Immunol Lett 1998; 64: 167-171.
56. Almawi WY, Beyhum HN, Rahme AA, Rieder MJ. Regulation of cytokine and cytokine receptor expression by glucocorticoids. J Leukocyte Biol 1996; 60: 563-572.
57. Schmidt-Choudhury A, Furuta GT, Lavigne JA, Galli SJ, Wershtl BK. The regulation of tumor necrosis factor-alpha production in murine mast cells: pentoxifylline or dexamethasone inhibits IgE-dependent production of TNF-alpha by distinct mechanisms. Cell Immunol 1996; 10: 140-146.
58. Alam R, Dejarnatt A, Stafford S, Forsythe PA, Kumar D, Grant JA. Selective inhibition of the cutaneous late but not immediate allergic response to antigens by misopristol, a PGE analogue. Am Rev Respir Dis 1993; 148: 1066-1070.
59. Pavord ID, Tattersfield AE. Bronchoprotective role for endogenous prostaglandin E2. Lancet 1995; 345: 436-438.
60. Ford-Hutchinson AW, Bray MA, Doig MV, Shipley ME, Smith MV. Leukotriene B a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature (London) 1980; 286: 264-265.
61. Ford-Hutchinson AW. Leukotriene B4 in inflammation. Crit Rev Immunol 1980; 10: 1-12.
62. Drazen JM, Anti-leukotrienes as novel anti-inflammatory treatments in asthma. Adv Exp Med Biol 2002; 507: 217-221.